Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use ; volume:16 ; number:1 ; day:1 ; month:6 ; year:2016 ; pages:1-11 ; date:12.2016
BMC infectious diseases ; 16, Heft 1 (1.6.2016), 1-11, 12.2016
- Urheber
-
Duintjer Tebbens, Radboud J.
- Beteiligte Personen und Organisationen
-
Hampton, Lee M.
Thompson, Kimberly M.
SpringerLink (Online service)
- DOI
-
10.1186/s12879-016-1537-8
- URN
-
urn:nbn:de:1111-2016060233819
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Duintjer Tebbens, Radboud J.
- Hampton, Lee M.
- Thompson, Kimberly M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation
Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns
Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
Phänotypische und molekulargenetische Untersuchungen an Poliovirus Serotyp 1-Isolaten eines Poliovirus-Dauerausscheiders
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation
The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation
Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns
Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
Phänotypische und molekulargenetische Untersuchungen an Poliovirus Serotyp 1-Isolaten eines Poliovirus-Dauerausscheiders
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation
The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation
Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns
Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
Phänotypische und molekulargenetische Untersuchungen an Poliovirus Serotyp 1-Isolaten eines Poliovirus-Dauerausscheiders